Literature DB >> 644566

Lysozyme and its presence in bovine milk and serum.

J Goudswaard, E C Bakker-de Koff, H P van Ravenswaaij-Kraan.   

Abstract

The literature on the presence of lysozyme in various biological fluids in physiological and pathological conditions is reviewed. Preliminary results of lysozyme estimations in bovine milk show that lysozyme levels are definitely higher in colostrum and mastitis milk than in normal milk. The biological role of the enzyme in the milk still has to be defined. On the other hand, lysozyme may interfere with microbiological screening techniques for penicillin in cow's milk; the lytic effect of purified human lysozyme on B. stearothermophilus var. calidolactis was demonstrated microscopically.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 644566

Source DB:  PubMed          Journal:  Tijdschr Diergeneeskd        ISSN: 0040-7453


  5 in total

1.  Antimicrobial residues in milk. Comparison of different agar diffusion methods.

Authors:  A Haapoja; H Korkeala
Journal:  Acta Vet Scand       Date:  1984       Impact factor: 1.695

Review 2.  Functional adaptations of the transcriptome to mastitis-causing pathogens: the mammary gland and beyond.

Authors:  Juan J Loor; Kasey M Moyes; Massimo Bionaz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-04       Impact factor: 2.673

3.  Evolution of the mammary gland defense system and the ontogeny of the immune system.

Authors:  Armond S Goldman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

Review 4.  Growth hormone and prolactin--molecular and functional evolution.

Authors:  Isabel A Forsyth; Michael Wallis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

5.  Cyclic lipodepsipeptides produced by Pseudomonas spp. naturally present in raw milk induce inhibitory effects on microbiological inhibitor assays for antibiotic residue screening.

Authors:  Wim Reybroeck; Matthias De Vleeschouwer; Sophie Marchand; Davy Sinnaeve; Kim Heylen; Jan De Block; Annemieke Madder; José C Martins; Marc Heyndrickx
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.